학술논문

Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Source
In The Lancet Haematology May 2021 8(5):e334-e343
Subject
Primary Research
Articles
Language
ISSN
2352-3026